Akebia Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKBA and other ETFs, options, and stocks.

About AKBA

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. 

CEO
John P. Butler
CEOJohn P. Butler
Employees
167
Employees167
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2007
Founded2007
Employees
167
Employees167

AKBA Key Statistics

Market cap
288.93M
Market cap288.93M
Price-Earnings ratio
-5.05
Price-Earnings ratio-5.05
Dividend yield
—
Dividend yield—
Average volume
3.72M
Average volume3.72M
High today
$1.44
High today$1.44
Low today
$1.33
Low today$1.33
Open price
$1.37
Open price$1.37
Volume
2.56M
Volume2.56M
52 Week high
$2.48
52 Week high$2.48
52 Week low
$0.5895
52 Week low$0.5895
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.